[1]袁叶青 包玉倩.外泌体参与糖尿病发生的机制研究[J].国际内分泌代谢杂志,2018,38(02):102-105.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
 Yuan Yeqing,Bao Yuqian.Researches on the mechanism of exosomes in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(02):102-105.[doi:10.3760/cma.j.issn.1673-4157.2018.02.008]
点击复制

外泌体参与糖尿病发生的机制研究()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年02期
页码:
102-105
栏目:
综述
出版日期:
2018-03-20

文章信息/Info

Title:
Researches on the mechanism of exosomes in diabetes mellitus
作者:
袁叶青 包玉倩
200233 上海交通大学附属第六人民医院内分泌代谢科, 上海市糖尿病临床医学中心
Author(s):
Yuan Yeqing Bao Yuqian
Department of Endocrinology and Metabolism, Shanghai Jiaotong Affiliated Sixth People's Hospital, Shanghai Clinical Center for Diabetes, Shanghai 200233, China
关键词:
外泌体 糖尿病 自身免疫 胰岛β细胞
Keywords:
Exosomes Diabetes mellitus Autoimmunity Islet β cells
DOI:
10.3760/cma.j.issn.1673-4157.2018.02.008
摘要:
外泌体是纳米级细胞外囊泡,广泛分布于生物细胞内和循环体液中。其可通过释放不同的囊泡内容物与靶细胞发生特定的作用。作为一种新的细胞间信号交流方式,外泌体可以通过激活自身免疫、增加β细胞凋亡以及调节细胞因子而影响胰岛β细胞功能和胰岛素敏感性,从而参与糖尿病的发生。因此,深入研究外泌体在糖尿病发病机制中的作用可能为糖尿病的诊疗提供一个新思路。
Abstract:
Exosomes,a class of nanoscale extracellular vesicles, are widely distributed in biological cells and circulating fluids. Exosomes interact with recipient cells by releasing specific cargos. As a novel signaling pathway of intercellular communication, exosomes participate in the pathogenesis of diabetes mellitus by influencing islet β cells function, which involves autoimmune responses activation and increased apoptosis of islets β cells, and insulin sensitivity mediated by cytokine. Further researches on the role of exosomes in the pathogenesis of diabetes may provide a new idea for the diagnosis and treatment of diabetes mellitus.

参考文献/References:


[1] Ingelfinger JR,Jarcho JA.Increase in the incidence of diabetes and its implications[J].N Engl J Med,2017,376(15):1473-1474.DOI:10.1056/NEJMe1616575.
[2] Diamant M,Nieuwland R,Pablo RF,et al.Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus[J].Circulation,2002,106(19):2442-2447.
[3] Trams EG,Lauter CJ,Salem N Jr,et al.Exfoliation of membrane ecto-enzymes in the form of micro-vesicles[J].Biochim Biophys Acta,1981,645(1):63-70.
[4] Johnstone RM,Adam M,Hammond JR,et al.Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles(exosomes)[J].J Biol Chem,1987,262(19):9412-9420.
[5] Lakhter AJ,Sims EK.Minireview: emerging roles for extracellular vesicles in diabetes and related metabolic disorders[J].Mol Endocrinol,2015,29(11):1535-1548. DOI:10.1210/me.2015-1206.
[6] Colombo M,Raposo G,Théry C.Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles[J].Annu Rev Cell Dev Biol,2014,30:255-289.DOI:10.1146/annurev-cellbio-101512-122326.
[7] Hanson PI,Cashikar A.Multivesicular body morphogenesis[J].Annu Rev Cell Dev Biol,2012,28:337-362.DOI:10.1146/annurev-cellbio-092910-154152.
[8] Mazurov D,Barbashova L,Filatov A.Tetraspanin protein CD9 interacts with metalloprotease CD10 and enhances its release via exosomes[J].FEBS J,2013,280(5):1200-1213.DOI:10.1111/febs.12110.
[9] Trajkovic K,Hsu C,Chiantia S,et al.Ceramide triggers budding of exosome vesicles into multivesicular endosomes[J].Science,2008,319(5867):1244-1247.DOI:10.1126/science.1153124.
[10] Hyenne V,Labouesse M,Goetz JG.The small GTPase Ral orchestrates MVB biogenesis and exosome secretion[J].Small GTPases,2016,22:1-7.DOI:10.1080/21541248.2016.1251378.
[11] Sinha S,Hoshino D,Hong NH,et al.Cortactin promotes exosome secretion by controlling branched actin dynamics[J].J Cell Biol,2016,214(2):197-213.DOI:10.1083/jcb.201601025.
[12] Bobrie A,Colombo M,Raposo G,et al.Exosome secretion: molecular mechanisms and roles in immune responses[J].Traffic,2011,12(12):1659-1668.DOI:10.1111/j.1600-0854.2011.01225.x.
[13] Robbins PD,Morelli AE. Regulation of immune responses by extracellular vesicles[J].Nat Rev Immunol,2014,14(3):195-208.DOI:10.1038/nri3622.
[14] Cai Z,Yang F,Yu L,et al.Activated T cell exosomes promote tumor invasion via Fas signaling pathway[J].J Immunol,2012,188(12):5954-5961.DOI:10.4049/jimmunol.1103466.
[15] Chivet M,Hemming F,Pernet-Gallay K,et al.Emerging role of neuronal exosomes in the central nervous system[J].Front Physiol,2012,3:145.DOI:10.3389/fphys.2012.00145.
[16] Quesenberry PJ,Aliotta JM.Cellular phenotype switching and microvesicles[J].Adv Drug Deliv Rev,2010,62(12):1141-1148.DOI:10.1016/j.addr.2010.06.001.
[17] Timmers L,Lim SK,Hoefer IE,et al.Human mesenchymal stem cell-conditioned medium improves cardiac function following myocardial infarction[J].Stem Cell Res,2011,6(3):206-214.DOI:10.1016/j.scr.2011.01.001.
[18] Teng Y,Ren Y,Hu X,et al.MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression[J].Nat Commun,2017,8:14448.DOI:10.1038/ncomms14448.
[19] Lee MJ,Park DH,Kang JH.Exosomes as the source of biomarkers of metabolic diseases[J].Ann Pediatr Endocrinol Metab,2016,21(3):119-125.DOI:10.6065/apem.2016.21.3.119.
[20] Koeck ES,Iordanskaia T,Sevilla S,et al.Adipocyte exosomes induce transforming growth factor beta pathway dysregulation in hepatocytes: a novel paradigm for obesity-related liver disease[J].J Surg Res,2014,192(2):268-275.DOI:10.1016/j.jss.2014.06.050.
[21] Cianciaruso C,Phelps EA,Pasquier M,et al.Primary human and Rat β-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity[J].Diabetes,2017,66(2):460-473.DOI:10.2337/db16-0671.
[22] Eizirik DL,Cardozo AK,Cnop M.The role for endoplasmic reticulum stress in diabetes mellitus[J].Endocr Rev,2008,29(1):42-61.DOI:10.1210/er.2007-0015.
[23] Rahman MJ,Regn D,Bashratyan R,et al.Exosomes released by islet-derived mesenchymal stem cells trigger autoimmuneresponses in NOD mice[J].Diabetes,2014,63(3):1008-1020.DOI:10.2337/db13-0859.
[24] Sheng H,Hassanali S,Nugent C,et al.Insulinoma-released exosomes or microparticles are immunostimulatory and can activate autoreactive T cells spontaneously developed in nonobese diabetic mice[J].J Immunol,2011,187(4):1591-1600.DOI:10.4049/jimmunol.1100231.
[25] Osmai M,Osmai Y,Bang-Berthelsen CH,et al.MicroRNAs as regulators of beta-cell function and dysfunction[J].Diabetes Metab Res Rev,2016,32(4):334-349.DOI:10.1002/dmrr.2719.
[26] Guay C,Jacovetti C,Nesca V,et al.Emerging roles of non-coding RNAs in pancreatic β-cell function and dysfunction[J].Diabetes Obes Metab,2012,14(Suppl 3):12-21.DOI:10.1111/j.1463-1326.2012.01654.x.
[27] Guay C,Menoud V,Rome S,et al.Horizontal transfer of exosomal microRNAs transduce apoptotic signals between pancreatic beta-cells[J].Cell Commun Signal,2015,13:17.DOI:10.1186/s12964-015-0097-7.
[28] Guilherme A,Virbasius JV,Puri V,et al.Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes[J].Nat Rev Mol Cell Biol,2008,9(5):367-377.DOI:10.1038/nrm2391.
[29] Deng ZB,Poliakov A,Hardy RW,et al.Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance[J].Diabetes,2009,58(11):2498-2505.DOI:10.2337/db09-0216.
[30] Uysal KT,Scheja L,Wiesbrock SM,et al.Improved glucose and lipid metabolism in genetically obese mice lacking aP2[J].Endocrinology,2000,141(9):3388-3396.DOI:10.1210/endo.141.9.7637.
[31] Ertunc ME,Sikkeland J,Fenaroli F,et al.Secretion of fatty acid binding protein aP2 from adipocytes through a nonclassical pathway in response to adipocyte lipase activity[J].J Lipid Res,2015,56(2):423-434.DOI:10.1194/jlr.M055798.
[32] Lawson C,Vicencio JM,Yellon DM,et al.Microvesicles and exosomes: new players in metabolic and cardiovascular disease[J].J Endocrinol,2016,228(2):R57-R71.DOI:10.1530/JOE-15-0201.

相似文献/References:

[1]李春睿,王静,陈峰,等.GLP-1受体激动剂对糖尿病患者肾功能的影响[J].国际内分泌代谢杂志,2014,(06):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
 Li Chunrui*,Wang Jing,Chen Feng,et al.Effects of GLP-1 receptor agonists on renal function of diabetics[J].International Journal of Endocrinology and Metabolism,2014,(02):401.[doi:10.3760/cma.j.issn.1673-4157.2014.06.011]
[2]黄珊珊,鲁一兵.长链非编码RNA与糖尿病[J].国际内分泌代谢杂志,2015,(04):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
 Huang Shanshan*,Lu Yibing..Long non-coding RNA and diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(02):271.[doi:10.3760/cma.j.issn.1673-4157.2015.04.016]
[3]高瑞霄,姚朱华,冯凭,等.尿8-羟基脱氧鸟苷在2型糖尿病及糖尿病合并冠心病患者中的临床意义[J].国际内分泌代谢杂志,2014,(05):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
 Gao Ruixiao*,Yao Zhuhua,Feng Ping,et al.The clinical significance of urinary 8-hydroxy deoxyguanosine in patients with type 2 diabetes mellitus and diabetic patients with coronary heart disease[J].International Journal of Endocrinology and Metabolism,2014,(02):295.[doi:10.3760/cma.j.issn.1673-4157.2014.05.002]
[4]郑佳,肖新华.葡萄糖稳态的中枢调控作用机制 ——2014年美国糖尿病协会“杰出科学成就奖” 演讲报告解读[J].国际内分泌代谢杂志,2014,(05):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
 Zheng Jia,Xiao Xinhua.The mechanisms of central nervous system in the control of glucose homeostasis--A summary of 2014 ADA "Outstanding Scientific Achievement Award" Lecture[J].International Journal of Endocrinology and Metabolism,2014,(02):305.[doi:10.3760/cma.j.issn.1673-4157.2014.05.004]
[5]唐勤,邵莉.蛋白乙酰化与胰岛素分泌[J].国际内分泌代谢杂志,2014,(05):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
 Tang Qin,Shao Li..Protein acetylation and insulin secretion[J].International Journal of Endocrinology and Metabolism,2014,(02):313.[doi:10.3760/cma.j.issn.1673-4157.2014.05.007]
[6]卢婷婷,任思佳,沈捷.人群迁徙对糖尿病患病率的影响及其相关因素[J].国际内分泌代谢杂志,2014,(05):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
 Lu Tingting,Ren Sijia,Shen Jie..Impact of migration on prevalence of diabetes and risk factors[J].International Journal of Endocrinology and Metabolism,2014,(02):327.[doi:10.3760/cma.j.issn.1673-4157.2014.05.011]
[7]包薇萍,陈国芳,刘超.DPP-4抑制剂的肾保护作用[J].国际内分泌代谢杂志,2014,(05):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
 Bao Weiping,Chen Guofang,Liu Chao..Renal protective effects of dipeptidyl peptidase-4 inhibitors[J].International Journal of Endocrinology and Metabolism,2014,(02):337.[doi:10.3760/cma.j.issn.1673-4157.2014.05.014]
[8]孟庆冬,陶红.巨噬细胞凋亡与糖尿病动脉粥样硬化[J].国际内分泌代谢杂志,2014,(05):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
 Meng Qingdong,Tao Hong..Macrophage apoptosis and diabetic atherosclerosis[J].International Journal of Endocrinology and Metabolism,2014,(02):340.[doi:10.3760/cma.j.issn.1673-4157.2014.05.015]
[9]赵荷珺 洪天配.胰高血糖素样肽-1类药物与胰腺安全性[J].国际内分泌代谢杂志,2015,(05):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
 Zhao Hejun*,Hong Tianpei..Glucagon-like peptide-1-based therapies and pancreatic safety[J].International Journal of Endocrinology and Metabolism,2015,(02):319.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.008]
[10]吕丹 李晓思 陈树春 王泽普.Betatrophin:糖尿病再生治疗的新希望[J].国际内分泌代谢杂志,2015,(05):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]
 Lyu Dan*,Li Xiaosi,Chen Shuchun,et al.Betatrophin:new hope for regeneration therapy of diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):351.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.016]

备注/Memo

备注/Memo:

通信作者:包玉倩,Email:byq522@163.com
更新日期/Last Update: 1900-01-01